Example with LRC-TriCEPS applied to human primary T-cells
The LRC-TriCEPS applied to human primary T-cells
Zellwerk GmbH, Germany and Dualsystems Biotech AG, Zurich joined forces and conducted successfully an entire LRC- TriCEPSTM experiment on primary T-cells.
Positive control ligand (included in the kit): Anti-CD28 antibody the protein CD28
Ligand of interest: Anti-TCR2 α/β antibody
Cells used: human primary T-cells
Read all detail from the experiment about Example of LRC-TriCEPS T-cells